Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Mankind Pharma IPO and Signatureglobal India IPO.
Mankind Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Signatureglobal India IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Mankind Pharma IPO | Signatureglobal India IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited Iifl Securities Ltd Jefferies India Private Limited J.P. Morgan India Private Limited |
ICICI Securities Limited Axis Capital Limited Kotak Mahindra Capital Company Limited |
| Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | Anchor Investor |
Anchor Investor |
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Signatureglobal India IPO is up to ₹730.00 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Signatureglobal India IPO is ₹385.00 per share.
| Mankind Pharma IPO | Signatureglobal India IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹1 per share |
| Issue Price (Lower) | ₹1,026.00 per share | ₹366.00 per share |
| Issue Price (Upper) | ₹1,080.00 per share | ₹385.00 per share |
| Issue Price (Final) | ₹1,080.00 per share | ₹385.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 13 shares | 38 shares |
| Fresh Issue Size | 1,56,62,338 shares | |
| Fresh Issue Size (Amount) | up to ₹603.00 Cr | |
| OFS Issue Size | 4,00,58,844 shares | 32,98,701 shares |
| OFS Issue Size (Amount) | up to ₹4,326.36 Cr | up to ₹127.00 Cr |
| Issue Size Total | 4,00,58,844 shares | 1,89,61,039 shares |
| Issue Size Total (Amount) | up to ₹4,326.36 Cr | up to ₹730.00 Cr |
Mankind Pharma IPO opens on Apr 25, 2023, while Signatureglobal India IPO opens on Sep 20, 2023. The closing date of Mankind Pharma IPO and Signatureglobal India IPO is Apr 27, 2023, and Sep 22, 2023, respectively.
| Mankind Pharma IPO | Signatureglobal India IPO | |
|---|---|---|
| Anchor Bid Date | Apr 24, 2023 | Sep 18, 2023 |
| Issue Open | Apr 25, 2023 | Sep 20, 2023 |
| Issue Close | Apr 27, 2023 | Sep 22, 2023 |
| Basis Of Allotment (Tentative) | May 03, 2023 | Sep 27, 2023 |
| Initiation of Refunds (Tentative) | May 04, 2023 | Sep 29, 2023 |
| Credit of Share (Tentative) | May 05, 2023 | Oct 03, 2023 |
| Listing date (Tentative) | May 09, 2023 | Sep 27, 2023 |
| Anchor Lockin End date 1 | Jun 02, 2023 | Oct 27, 2023 |
| Anchor Lockin End date 2 | Aug 01, 2023 | Dec 26, 2023 |
Mankind Pharma IPO P/E ratio is 32.5, as compared to Signatureglobal India IPO P/E ratio of .
| Mankind Pharma IPO | Signatureglobal India IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
Amount in ₹ Crore |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 79.00% | 78.36% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 76.50% | 69.63% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹43263.60 Cr. | ₹5409.66 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 27.60%% | -134.0%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.10%% | 1%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 34.1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹33.20 | ₹-5.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 27.70%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mankind Pharma IPO retail investors (RII) are offered 1,40,20,596 shares while in Signatureglobal India IPO retail investors are offered 1,40,20,596 shares. Qualified institutional buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 59,48,079 shares in Signatureglobal India IPO.
| Mankind Pharma IPO | Signatureglobal India IPO | |
|---|---|---|
| Anchor Investor Reserveration | 1,20,17,652 shares | 82,72,700 shares |
| Market Maker Reserveration | ||
| QIB | 80,11,769 shares | 59,48,079 shares |
| NII | 60,08,827 shares | 28,44,156 shares |
| RII | 1,40,20,596 shares | 18,96,104 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 2,80,41,192 shares | 1,06,88,339 shares |
Mankind Pharma IPO subscribed 15.32x in total, whereas Signatureglobal India IPO subscribed 12.50x.
| Mankind Pharma IPO | Signatureglobal India IPO | |
|---|---|---|
| QIB (times) | 49.16x | 13.37x |
| NII (times) | 3.80x | 14.24x |
| Big NII (times) | 4.99x | 16.60x |
| Small NII (times) | 1.41x | 9.53x |
| RII (times) | 0.92x | 7.17x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 15.32x | 12.50x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
